SL-01 T19779
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.
CAS nr:
26049-94-5
Purity:
98%
Molecular Weight:
331,79
SMILES:
O=C(OCC1=CC=CC=C1)N[C@H](C(CCl)=O)CC2=CC=CC=C2
Formula:
C18H18ClNO3
Pathway:
Target:
